跳至主要内容
临床试验/IRCT20220504054735N1
IRCT20220504054735N1已完成3 期

Serum magnesium levels in type 2 diabetic patients and effect of magnesium supplement therapy in glycemic control and insulin resistance of these patients

Tabriz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • An adult patient with type 2 diabetes who has been diagnosed and treated for at least one year and been treated with oral medications only.
  • The patient's HbA1c level should be between 7 to 10.
  • The patient should be satisfied to participate in the study.

排除标准

  • Injecting insulin and taking magnesium and calcium supplements, calcium channel blockers, and diuretics.
  • Renal failure, elevated liver enzymes, inflammatory disease, chronic diarrhea, and pregnancy.
  • Participants should not have been admitted to another clinical trial at the same time.

研究者

相似试验